Rachel E. Wittenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rachel E. Wittenberg has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Helen McShane
Nuffield Department of Medicine, University of Oxford, Oxford, UK
6 shared publications Iman Satti
The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
5 shared publicationsStephanie A. Harris
The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
4 shared publications- Deniz Cizmeci
Ragon Institute of MGH, MIT, and Harvard, Cambridge, USA
3 shared publications - Helen A. Fletcher
London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
3 shared publications Rachel Tanner
The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 22 (4) , 87-101
Genetic Causes of Thoracic Aortic Aneurysm: A Review
Thoracic aortic aneurysm (TAA) is an important cause of cardiovascular morbidity and mortality. TAA may occur due to inheritable genetic variants affecting the TGFβ signaling cascade, the extracellular matrix, or smooth muscle contraction, which are essential to maintain connective tissue homeostasis and vascular wall integrity. In this review, we summarize the available evidence on the genetics of thoracic aortic aneurysm including known syndromic and non-syndromic hereditary thoracic aortic disorders, the increasingly recognized role of polygenic risk, and the association of TAA with other arteriopathies. We also discuss the evolving role of genetic testing for patients with TAA. A better understanding of genetic predictors for TAA has the potential to improve screening, risk stratification, and the medical and surgical management for this patient population.
- 15 September 2026
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 22 (4) , 87-101
Open AccessGenetic Causes of Thoracic Aortic Aneurysm: A Review
Thoracic aortic aneurysm (TAA) is an important cause of cardiovascular morbidity and mortality. TAA may occur due to inheritable genetic variants affecting the TGFβ signaling cascade, the extracellular matrix, or smooth muscle contraction, which are essential to maintain connective tissue homeostasis and vascular wall integrity. In this review, we summarize the available evidence on the genetics of thoracic aortic aneurysm including known syndromic and non-syndromic hereditary thoracic aortic disorders, the increasingly recognized role of polygenic risk, and the association of TAA with other arteriopathies. We also discuss the evolving role of genetic testing for patients with TAA. A better understanding of genetic predictors for TAA has the potential to improve screening, risk stratification, and the medical and surgical management for this patient population.
- Open Access
- 12 August 2025
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 21 (4) , 54-64
Coronary Artery Anomalies in Review: Anomalous Origin, Aneurysms, and Fistulae
Coronary artery anomalies are rare congenital abnormalities involving abnormal coronary artery origin and incomplete/abnormal vessel development. These anomalies encompass a broad anatomical spectrum with varied clinical presentations ranging from sudden cardiac arrest in young athletes to incidental findings in asymptomatic adults. While more data on anatomy and clinical presentation has emerged in the last decade, management remains highly individualized, guided by clinical presentation, anatomical characteristics, and patient preferences. This review provides an overview of each anomaly and recent advances in imaging, surgical planning, and risk stratification. We also highlight the challenges in optimizing management strategies, addressing gaps in evidence, and achieving consensus to refine risk stratification tools and support clinical decision-making.
- 12 August 2025
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 21 (4) , 54-64
Open AccessCoronary Artery Anomalies in Review: Anomalous Origin, Aneurysms, and Fistulae
Coronary artery anomalies are rare congenital abnormalities involving abnormal coronary artery origin and incomplete/abnormal vessel development. These anomalies encompass a broad anatomical spectrum with varied clinical presentations ranging from sudden cardiac arrest in young athletes to incidental findings in asymptomatic adults. While more data on anatomy and clinical presentation has emerged in the last decade, management remains highly individualized, guided by clinical presentation, anatomical characteristics, and patient preferences. This review provides an overview of each anomaly and recent advances in imaging, surgical planning, and risk stratification. We also highlight the challenges in optimizing management strategies, addressing gaps in evidence, and achieving consensus to refine risk stratification tools and support clinical decision-making.
- Open Access
- 29 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG
The development of an effective vaccine against Mycobacterium tuberculosis is hampered by an incomplete understanding of immunoprotective mechanisms. We utilise an aerosol human challenge model using attenuated Mycobacterium bovis BCG, in BCG-naïve UK adults. The primary endpoint of this study (NCT03912207) was to characterise the early immune responses induced by aerosol BCG infection, the secondary endpoint was to identify immune markers associated with in-vitro protection. Blinded volunteers were randomised to inhale 1 × 107 CFU aerosolised BCG or 0.9% saline (20:6); and sequentially allocated to bronchoscopy at day 2 or 7 post-inhalation (10 BCG, 3 saline each timepoint). In the bronchoalveolar lavage post-aerosol BCG infection, there was an increase in frequency of eosinophils, neutrophils, NK cells and Donor-Unrestricted T cells at day 7, and the frequency of antigen presenting cells decreased at day 7 compared with day 2. The frequency of interferon-gamma+ BCG-specific CD4+ T cells increased in the BAL and peaked in the blood at day 7 post-BCG infection compared to day 2. BAL cells at day 2 and day 7 upregulated gene pathways related to phagocytosis, MHC-II antigen loading, T cell activation and proliferation. BCG’s lack of key virulence factors and its failure to induce granulomas, may mean the observed immune responses do not fully recapitulate Mycobacterium tuberculosis infection. However, human infection models can provide unique insights into early immune mechanisms, informing vaccine design for complex pathogens.
- 29 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessEarly mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG
The development of an effective vaccine against Mycobacterium tuberculosis is hampered by an incomplete understanding of immunoprotective mechanisms. We utilise an aerosol human challenge model using attenuated Mycobacterium bovis BCG, in BCG-naïve UK adults. The primary endpoint of this study (NCT03912207) was to characterise the early immune responses induced by aerosol BCG infection, the secondary endpoint was to identify immune markers associated with in-vitro protection. Blinded volunteers were randomised to inhale 1 × 107 CFU aerosolised BCG or 0.9% saline (20:6); and sequentially allocated to bronchoscopy at day 2 or 7 post-inhalation (10 BCG, 3 saline each timepoint). In the bronchoalveolar lavage post-aerosol BCG infection, there was an increase in frequency of eosinophils, neutrophils, NK cells and Donor-Unrestricted T cells at day 7, and the frequency of antigen presenting cells decreased at day 7 compared with day 2. The frequency of interferon-gamma+ BCG-specific CD4+ T cells increased in the BAL and peaked in the blood at day 7 post-BCG infection compared to day 2. BAL cells at day 2 and day 7 upregulated gene pathways related to phagocytosis, MHC-II antigen loading, T cell activation and proliferation. BCG’s lack of key virulence factors and its failure to induce granulomas, may mean the observed immune responses do not fully recapitulate Mycobacterium tuberculosis infection. However, human infection models can provide unique insights into early immune mechanisms, informing vaccine design for complex pathogens.
- 8 February 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (2) , e70107
Functional Status Trajectory and Survival for Adult Patients Undergoing Heart Transplantation
Background: Transplantation is a critical treatment for end‐stage heart disease and improves length and quality of life. We investigated predictors of functional status improvement following transplant and the association between functional status trajectory and survival.Methods: We conducted a retrospective cohort study using Scientific Registry of Transplant Recipients data on 34 009 US adults who underwent heart transplant 2006–2021. Functional status was measured using the Karnofsky Performance Scale (KPS; 0%–100%). Linear regression with stepwise selection was used to identify predictors of KPS trajectories. Kaplan–Meier curves and adjusted Cox proportional hazard models were used to compare survival.Results: Mean KPS was low at listing (47.9%) and transplant (45.6%) and increased to 85.7% and 89.2% at 1‐ and 5‐years posttransplant. Independent predictors of KPS trajectory in the first year included hypertension, diabetes, BMI, prior tobacco, previous malignancy, age, sex, education level, insurance type, etiology of heart disease, prior cardiac surgery, “1A” waitlist priority, and hospitalization status. KPS trajectory during the waitlist period and the first year posttransplant predicted survival, independent of baseline KPS. Decrease in KPS > −30% and −30% to < 0% in the first year were associated with 5.74 (3.45–9.56) and 2.09 (1.69–2.59) times higher mortality than stable KPS after adjusting for baseline KPS and other factors. Poor KPS trajectory in the waitlist period was similarly associated with higher mortality.Conclusions: Functional status improvement is an important outcome following heart transplantation, and KPS trajectory predicts survival. Most patients achieve high KPS, but clinical and social interventions may optimize KPS trajectory for high‐risk patients.
- 8 February 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (2) , e70107
Functional Status Trajectory and Survival for Adult Patients Undergoing Heart Transplantation
Background: Transplantation is a critical treatment for end‐stage heart disease and improves length and quality of life. We investigated predictors of functional status improvement following transplant and the association between functional status trajectory and survival.Methods: We conducted a retrospective cohort study using Scientific Registry of Transplant Recipients data on 34 009 US adults who underwent heart transplant 2006–2021. Functional status was measured using the Karnofsky Performance Scale (KPS; 0%–100%). Linear regression with stepwise selection was used to identify predictors of KPS trajectories. Kaplan–Meier curves and adjusted Cox proportional hazard models were used to compare survival.Results: Mean KPS was low at listing (47.9%) and transplant (45.6%) and increased to 85.7% and 89.2% at 1‐ and 5‐years posttransplant. Independent predictors of KPS trajectory in the first year included hypertension, diabetes, BMI, prior tobacco, previous malignancy, age, sex, education level, insurance type, etiology of heart disease, prior cardiac surgery, “1A” waitlist priority, and hospitalization status. KPS trajectory during the waitlist period and the first year posttransplant predicted survival, independent of baseline KPS. Decrease in KPS > −30% and −30% to < 0% in the first year were associated with 5.74 (3.45–9.56) and 2.09 (1.69–2.59) times higher mortality than stable KPS after adjusting for baseline KPS and other factors. Poor KPS trajectory in the waitlist period was similarly associated with higher mortality.Conclusions: Functional status improvement is an important outcome following heart transplantation, and KPS trajectory predicts survival. Most patients achieve high KPS, but clinical and social interventions may optimize KPS trajectory for high‐risk patients.
- Open Access
- 31 October 2024
- Published by Elsevier in JACC: Advances
- Vol. 3 (12) , 101332
Associations With Adverse Postoperative Outcomes in Children Undergoing Atrial Septal Defect Closure in Lower-Resource Settings
- 31 October 2024
- Published by Elsevier in JACC: Advances
- Vol. 3 (12) , 101332
Open AccessAssociations With Adverse Postoperative Outcomes in Children Undergoing Atrial Septal Defect Closure in Lower-Resource Settings
- Open Access
- 2 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (13) , e032662
Preoperative Malnutrition Increases Risk of In‐Hospital Mortality, Major Infection, and Longer Intensive Care Unit Stay After Ventricular Septal Defect Closure
Background: High energy requirements and poor feeding can lead to growth failure in patients with ventricular septal defect (VSD), but effects of preoperative malnutrition on surgical outcomes are poorly understood, especially in low‐resource settings. Methods and Results: We analyzed a cohort of children Z score, <−3), moderate wasting (−3Z score≤−2), underweight (weight‐for‐age Z score, ≤−2), and stunting (height‐for‐age Z score, ≤−2) according to World Health Organization Child Growth Standards. Among 10 966 children undergoing VSD closure in the analyzed cohort, 8136 (74%) were membranous VSDs. Median age was 9.6 months (interquartile range, 3.6–12.0), and 4088 (37.3%) had wasting/severe wasting, 5029 (45.9%) had underweight, and 3515 (32.1%) had stunting. There were 4749 (43.3%) children who met the criteria for ≥2 malnutrition categories. Overall, 84 patients (0.8%) died in‐hospital, and 199 (1.8%) had major infection. Severe wasting (OR, 3.38 [95% CI, 1.55–7.35]; P =0.002), underweight (OR, 6.46 [95% CI, 2.81–14.8]; P P =0.003) were independent predictors of mortality. Similar results were observed for infection and duration of intensive care unit stay. Underweight was the strongest predictor of adverse outcomes. Children meeting criteria for all 3 (stunting, wasting, and underweight) had 17.2 times higher odds of mortality ( P <0.001) than nonmalnourished children. Conclusions: Malnutrition was associated with mortality, infection, and longer intensive care unit stay in a global cohort of children undergoing VSD closure.
- 2 July 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (13) , e032662
Open AccessPreoperative Malnutrition Increases Risk of In‐Hospital Mortality, Major Infection, and Longer Intensive Care Unit Stay After Ventricular Septal Defect Closure
Background: High energy requirements and poor feeding can lead to growth failure in patients with ventricular septal defect (VSD), but effects of preoperative malnutrition on surgical outcomes are poorly understood, especially in low‐resource settings. Methods and Results: We analyzed a cohort of children Z score, <−3), moderate wasting (−3Z score≤−2), underweight (weight‐for‐age Z score, ≤−2), and stunting (height‐for‐age Z score, ≤−2) according to World Health Organization Child Growth Standards. Among 10 966 children undergoing VSD closure in the analyzed cohort, 8136 (74%) were membranous VSDs. Median age was 9.6 months (interquartile range, 3.6–12.0), and 4088 (37.3%) had wasting/severe wasting, 5029 (45.9%) had underweight, and 3515 (32.1%) had stunting. There were 4749 (43.3%) children who met the criteria for ≥2 malnutrition categories. Overall, 84 patients (0.8%) died in‐hospital, and 199 (1.8%) had major infection. Severe wasting (OR, 3.38 [95% CI, 1.55–7.35]; P =0.002), underweight (OR, 6.46 [95% CI, 2.81–14.8]; P P =0.003) were independent predictors of mortality. Similar results were observed for infection and duration of intensive care unit stay. Underweight was the strongest predictor of adverse outcomes. Children meeting criteria for all 3 (stunting, wasting, and underweight) had 17.2 times higher odds of mortality ( P <0.001) than nonmalnourished children. Conclusions: Malnutrition was associated with mortality, infection, and longer intensive care unit stay in a global cohort of children undergoing VSD closure.
- Open Access
- 1 April 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 505-508
Robot-Assisted Laparoscopic Reduction of Gastroesophageal Intussusception With Gastropexy
- 1 April 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 505-508
Open AccessRobot-Assisted Laparoscopic Reduction of Gastroesophageal Intussusception With Gastropexy
- Open Access
- 3 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Tuberculosis vaccine development is hindered by the lack of validated immune correlates of protection. Exploring immune correlates of risk of disease and/or infection in prospective samples can inform this field. We investigate whether previously identified immune correlates of risk of TB disease also associate with increased risk of M.tb infection in BCG-vaccinated South African infants, who became infected with M.tb during 2-3 years of follow-up. M.tb infection is defined by conversion to positive reactivity in the QuantiFERON test. We demonstrate that inflammation and immune activation are associated with risk of M.tb infection. Ag85A-specific IgG is elevated in infants that were subsequently infected with M.tb, and this is coupled with upregulated gene expression of immunoglobulin-associated genes and type-I interferon. Plasma levels of IFN- $$\alpha$$ 2, TNF- $$\alpha$$ , CXCL10 (IP-10) and complement C2 are also higher in infants that were subsequently infected with M.tb.- 3 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Open AccessInflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Tuberculosis vaccine development is hindered by the lack of validated immune correlates of protection. Exploring immune correlates of risk of disease and/or infection in prospective samples can inform this field. We investigate whether previously identified immune correlates of risk of TB disease also associate with increased risk of M.tb infection in BCG-vaccinated South African infants, who became infected with M.tb during 2-3 years of follow-up. M.tb infection is defined by conversion to positive reactivity in the QuantiFERON test. We demonstrate that inflammation and immune activation are associated with risk of M.tb infection. Ag85A-specific IgG is elevated in infants that were subsequently infected with M.tb, and this is coupled with upregulated gene expression of immunoglobulin-associated genes and type-I interferon. Plasma levels of IFN- $$\alpha$$ 2, TNF- $$\alpha$$ , CXCL10 (IP-10) and complement C2 are also higher in infants that were subsequently infected with M.tb. - Open Access
- 17 May 2022
- Published by Springer Nature in Research Square
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Tuberculosis vaccine development is hindered by the lack of validated immune correlates of protection. Exploring immune correlates of risk of disease and/or infection in prospective samples can inform this field. We investigated whether previously identified immune correlates of risk of TB disease also associate with increased risk of M.tb infection in BCG-vaccinated South African infants, who became infected with M.tb during 2–3 years of follow-up. M.tb infection was defined by conversion to positive reactivity in the QuantiFERON test. We demonstrate that inflammation and immune activation are associated with risk of M.tb infection. Ag85A-specific IgG was elevated in infants that were subsequently infected with M.tb, and this was coupled with upregulated gene expression of immunoglobulin-associated genes and type-I interferon. Plasma levels of IFN-\(\alpha\)2, TNF-\(\alpha\), CXCL10 (IP-10) and complement C2 were also higher in infants that were subsequently infected with M.tb.- 17 May 2022
- Published by Springer Nature in Research Square
Open AccessInflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Tuberculosis vaccine development is hindered by the lack of validated immune correlates of protection. Exploring immune correlates of risk of disease and/or infection in prospective samples can inform this field. We investigated whether previously identified immune correlates of risk of TB disease also associate with increased risk of M.tb infection in BCG-vaccinated South African infants, who became infected with M.tb during 2–3 years of follow-up. M.tb infection was defined by conversion to positive reactivity in the QuantiFERON test. We demonstrate that inflammation and immune activation are associated with risk of M.tb infection. Ag85A-specific IgG was elevated in infants that were subsequently infected with M.tb, and this was coupled with upregulated gene expression of immunoglobulin-associated genes and type-I interferon. Plasma levels of IFN-\(\alpha\)2, TNF-\(\alpha\), CXCL10 (IP-10) and complement C2 were also higher in infants that were subsequently infected with M.tb.